文献速递肺结节与肺癌

基于因果模型的低剂量CT与吸烟因素肺癌预测可行性

Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
PubMed 文献 · Thorax · 2019-03-12

该研究利用概率图模型整合人口学、临床和低剂量CT特征,从92例受训者中构建肺癌因果模型(LCCM),并在126例独立队列中验证。LCCM仅用结节数、血管数和戒烟年数即可区分良恶性结节,预测效能优于包括Brock简约模型在内的现有方法(p<0.001),且能识别30%的良性结节而不误分类癌结节。

要点

  • LCCM仅需结节数、血管数和戒烟年数即可区分肺结节良恶性。
  • LCCM预测效能显著优于Brock简约模型(p<0.001)。
  • LCCM可识别30%良性结节且不误分类癌结节,减少不必要随访。

核心结论

  • LCCM作为肺癌预测工具优于现有模型,但需更大规模前瞻性研究验证。

研究设计与样本

  • 研究纳入218例肺癌或良性结节受试者,其中92例来自匹兹堡肺癌筛查研究队列作为训练队列,126例作为独立验证队列。
  • 采用概率图模型整合人口学、临床数据和低剂量CT特征。

主要发现

  • 概率图模型识别出与恶性结节直接因果关联的三个变量:结节数、血管数和戒烟年数。
  • LCCM在训练和验证队列中均显示,结合低剂量CT特征可大幅提高预测准确性。
  • LCCM优于包括Brock简约模型在内的现有方法(p<0.001)。
  • 结节周围血管数这一既往未用于预测模型的特征显著提高预测效率。
  • 基于验证队列结果,LCCM能识别30%的良性结节而不误分类癌结节。

关键数值与推荐

  • 原文报告96%的检出结节为假阳性。
  • LCCM与Brock简约模型比较的p值<0.001。
  • LCCM可识别30%的良性结节且不误分类癌结节。

临床怎么用

  • LCCM有望辅助减少不必要的随访和操作,但需前瞻性验证后用于临床。

局限性

  • 研究样本量有限(训练92例,验证126例),需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Low-dose CT (LDCT) is currently used in lung cancer screening of high-risk populations for early lung cancer diagnosis. However, 96% of individuals with detected nodules are false positives. METHODS: In order to develop an efficient early lung cancer predictor from clinical, demographic and LDCT features, we studied a total of 218 subjects with lung cancer or benign nodules. Probabilistic graphical models (PGMs) were used to integrate demographics, clinical data and LDCT features from 92 subjects (training cohort) from the Pittsburgh Lung Screening Study cohort. RESULTS: Learnt PGMs identified three variables directly (causally) linked to malignant nodules and the largest benign nodule and used them to build the Lung Cancer Causal Model (LCCM), which was validated in a separate cohort of 126 subjects. Nodule and vessel numbers and years since the subject quit smoking were sufficient to discriminate malignant from benign nodules. Comparison with existing predictors in the training and validation cohorts showed that (1) incorporating LDCT scan features greatly enhances predictive accuracy; and (2) LCCM improves cancer detection over existing methods, including the Brock parsimonious model (p<0.001). Notably, the number of surrounding vessels, a feature not previously used in predictive models, significantly improves predictive efficiency. Based on the validation cohort results, LCCM is able to identify 30% of the benign nodules without risk of misclassifying cancer nodules. DISCUSSION: LCCM shows promise as a lung cancer predictor as it is significantly improved over existing models. Validated in a larger, prospective study, it may help reduce unnecessary follow-up visits and procedures.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Raghu VK, Zhao W, Pu J, et al. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models. Thorax. 2019. PMID: 30862725. doi:10.1136/thoraxjnl-2018-212638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。